# A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

> clinical trial · VERIFIED · 2026-08-10

Status: RECRUITING · Sponsor: Daiichi Sankyo · Condition: Advanced Solid Tumor

- Company: Daiichi Sankyo
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06172478

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.